The Basics of Cancer Immunotherapy / edited by Haidong Dong, Svetomir N. Markovic
Colaborador(es): Dong, Haidong, editor literario | Markovic, Svetomir N, editor literario | SpringerLink (Online service)
.
Tipo de material:
E-bookSeries (Medicine (Springer-11650)).Editor: Cham : Springer International Publishing : Imprint: Springer, 2018Descripción: 1 recurso en línea (X, 160 páginas) : 8 ilustraciones, 4 ilustraciones a color.ISBN: 9783319706221.Tema: Cáncer -- Inmunoterapia
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC271 .I45 2018 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
Navegando Valencia Digital estanterías, Ubicación en estantería: Acceso Electrónico (UEV) Cerrar el navegador de estanterías (Oculta el navegador de estanterías)
| No hay imagen de cubierta disponible | ||||||||
| RC271 .E94 2020 EB Exercise Oncology Prescribing Physical Activity Before and After a Cancer Diagnosis | RC271.G45 2008 EB Gene Therapy of Cancer Methods and Protocols | RC271 .H36 2018 EB Handbook of Evidence-Based Radiation Oncology | RC271 .I45 2018 EB The Basics of Cancer Immunotherapy | RC271 .I46 2018 EB Immunotherapy for Pediatric Malignancies | RC271 .M64 2021 EB Manual on Image-Guided Brachytherapy of Inner Organs | RC271 .P53 2020 EB Plasma Cancer Therapy |
The Basic Concepts in Cancer Immunology and Immunotherapy -- Therapeutic Targets of FDA-approved Immunotherapies in Oncology -- Melanoma Immunotherapy -- Significance of Immune Checkpoints in Lung Cancer -- Immunotherapy for Genitourinary Cancers -- Next-generation Immunotherapy in Lymphoma Immunotherapy -- Combined Immunothepary with Conventional Cancer Treatment -- Immunotherapy for Other Malignancies -- Management of Immune-related Adverse Events from Immune Checkpoint Inhibitor Therapy -- Resources for Patients.
This book provides patients and their physicians (especially “non-oncologist” health care providers) with a clear and concise introduction to cancer immunotherapy, which, unlike traditional forms of cancer therapy, acts by boosting the patient’s own immune system to fight cancer. The unique features of cancer immunotherapy make its management, monitoring and side-effects different from those of traditional cancer therapy. Especially novel are the side effects of cancer immunotherapy, necessitating greater awareness for both patients and physicians in order to minimize complications of therapy. The patient-friendly, concise, easy-to-understand, and up-to-date knowledge presented in this book will inform patients about the benefits and risks of cancer immunotherapy, and help them and their care providers to understand how immunotherapy would control their unique disease. Researchers and academic professionals in the field of cancer immunotherapy will also find clear and useful information to help them communicate with patients or address unresolved problems. Some key features of the book are: Expertise. All editors and authors are scientists and oncologists specializing in cancer immunotherapy, and are involved in scientific discovery from the early stage of immune-checkpoint inhibitors to today’s daily patient care. Their insights, expertise and experience guarantee the high quality and authority in the science, medicine and practice of cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to meet their needs when considering immunotherapy. As an educational tool, this book will help the reader balance the risks and benefits based on both science and clinical facts, and therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease Specificity. Cancer is a complicated disease involving multiple stages and pathology. Its response to immunotherapy is individualized and varies depending on cancer types. The authors’ expertise in treating different types of cancers, including melanoma, lung, kidney, bladder, and lymphoma, provides disease-specific insights in applying immunotherapy to each disease.
No hay comentarios en este titulo.